Voloridge Investment Management’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-175,537
| Closed | -$2.66M | – | 1385 |
|
|
2023
Q4 | $2.66M | Buy |
+175,537
| New | +$2.66M | 0.01% | 762 |
|
|
2023
Q2 | – | Sell |
-147,923
| Closed | -$2.54M | – | 1605 |
|
|
2023
Q1 | $2.54M | Buy |
147,923
+1,894
| +1% | +$32.6K | 0.01% | 911 |
|
|
2022
Q4 | $2.94M | Sell |
146,029
-63,405
| -30% | -$1.28M | 0.02% | 857 |
|
|
2022
Q3 | $4.54M | Sell |
209,434
-70,076
| -25% | -$1.52M | 0.02% | 685 |
|
|
2022
Q2 | $7.85M | Buy |
279,510
+147,570
| +112% | +$4.15M | 0.04% | 529 |
|
|
2022
Q1 | $6.09M | Buy |
131,940
+47,028
| +55% | +$2.17M | 0.03% | 568 |
|
|
2021
Q4 | $7.14M | Buy |
84,912
+37,590
| +79% | +$3.16M | 0.04% | 574 |
|
|
2021
Q3 | $3.15M | Buy |
47,322
+20,208
| +75% | +$1.35M | 0.02% | 871 |
|
|
2021
Q2 | $1.44M | Buy |
+27,114
| New | +$1.44M | 0.01% | 1124 |
|